Four Decades for Justice
Ting S. Chen focuses her practice on mergers and acquisitions, corporate governance, and activism and takeover defense. Her clients have included Avon, Bacardi, British American Tobacco, DHT, DreamWorks Animation, Global Blood Therapeutics, Honeywell, IBM, Illumina, InterMune, Johnson & Johnson, Kraft, Lundbeck, New Senior, OneBeacon Insurance, Pitney Bowes, Qualcomm, SPANX, Starbucks, Thermo Fisher Scientific, The Washington Post, White Mountains Insurance and Zale Corporation.
Ms. Chen’s notable transactions include representing:
Ms. Chen has been named a “Dealmaker of the Year” by The American Lawyer and has been recognized in IFLR1000’s “Women Leaders – United States,” The Deal’s “Top Women in Dealmaking” and Crain’s New York Business’s “Notable Women in Law.” Ms. Chen has been recognized for her work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000, The Best Lawyers in America and Lawdragon. She has also been recognized by The Legal 500 US for her activist defense work, as well as her transactional work in the media and entertainment and technology industries.
Ms. Chen regularly speaks on topics concerning corporate governance and mergers and acquisitions law. She co‑chaired a panel entitled “Developments in Public Company M&A Securities Law” hosted by the International Bar Association’s Annual International Mergers & Acquisitions Conference and has spoken multiple times at the Practising Law Institute’s (PLI) “Doing Deals: The Art of M&A Transactional Practice” program.
Ms. Chen was born in Taipei, Taiwan. She received an A.B. summa cum laude from Harvard University in 2003, where she was elected to Phi Beta Kappa, and a J.D. from Stanford Law School in 2006.
Ms. Chen joined Cravath in 2006 and was elected a partner in 2013. She currently serves as a member of the Firm’s Diversity Committee.
Ms. Chen’s notable transactions include representing:
Ms. Chen has been named a “Dealmaker of the Year” by The American Lawyer and has been recognized in IFLR1000’s “Women Leaders – United States,” The Deal’s “Top Women in Dealmaking” and Crain’s New York Business’s “Notable Women in Law.” Ms. Chen has been recognized for her work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000, The Best Lawyers in America and Lawdragon. She has also been recognized by The Legal 500 US for her activist defense work, as well as her transactional work in the media and entertainment and technology industries.
Ms. Chen regularly speaks on topics concerning corporate governance and mergers and acquisitions law. She co‑chaired a panel entitled “Developments in Public Company M&A Securities Law” hosted by the International Bar Association’s Annual International Mergers & Acquisitions Conference and has spoken multiple times at the Practising Law Institute’s (PLI) “Doing Deals: The Art of M&A Transactional Practice” program.
Ms. Chen was born in Taipei, Taiwan. She received an A.B. summa cum laude from Harvard University in 2003, where she was elected to Phi Beta Kappa, and a J.D. from Stanford Law School in 2006.
Ms. Chen joined Cravath in 2006 and was elected a partner in 2013. She currently serves as a member of the Firm’s Diversity Committee.
American Bar Association
International Bar Association
New York State Bar Association
The American Lawyer
Best Lawyers in America
Chambers USA
Crain’s New York Business
The Deal
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Law360
Lawdragon
The Legal 500 US
New York Law Journal
Super Lawyers - Rising Stars - New York
Americas Women in Business Law Award ‑ Rising Star: Corporate, Euromoney Legal Media Group (2018, 2016)
Deals & Cases
October 17, 2023
On October 17, 2023, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”), a leading provider of next generation proteomics solutions, announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share in cash. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common shares and all of the American Depositary Shares. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
September 14, 2023
On September 11, 2023, Bacardi Limited (“Bacardi”), the largest privately held international spirits company in the world, announced the completion of a transaction that makes the family‑owned company the sole owner of ILEGAL Mezcal®, a leading super premium artisanal mezcal. Cravath is representing Bacardi in connection with the transaction.
Deals & Cases
May 25, 2023
On May 25, 2023, Illumina, a global leader in DNA sequencing and array‑based technologies, announced that Illumina shareholders have voted to elect eight of nine Illumina director nominees to the Board of Directors. Cravath represented Illumina in connection with these matters.
Deals & Cases
August 08, 2022
On August 8, 2022, Global Blood Therapeutics, Inc. (“GBT”), a biopharmaceutical company dedicated to the discovery, development and delivery of life‑changing treatments that provide hope to underserved patient communities, starting with sickle cell disease, and Pfizer Inc. (“Pfizer”) announced that the companies have entered into a definitive agreement under which Pfizer will acquire GBT. Under the terms of the transaction, Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash, for a total enterprise value of approximately $5.4 billion, including debt and net of cash acquired. Cravath is representing GBT in connection with the transaction.
Deals & Cases
June 21, 2022
On June 21, 2022, Pitney Bowes, a global shipping and mailing company, and Global‑e, a cross‑border end‑to‑end platform for brands and retailers, announced they have entered into a definitive agreement for Global‑e to acquire from Pitney Bowes the Borderfree cross‑border ecommerce solutions business. In addition, the companies will begin a strategic partnership and commercial relationship whereby Pitney Bowes will provide cross‑border ecommerce logistics services to Global‑e and its clients, and Pitney Bowes’s clients will receive access to cross‑border solutions on the Global‑e platform. Cravath is representing Pitney Bowes in connection with the transaction.
Activities & Publications
February 29, 2024
On February 28, 2024, Cravath partner Ting S. Chen participated in “Doing Deals 2024: The Art of M&A Transactional Practice,” a program presented by the Practising Law Institute in New York, which focused on the latest trends and developments in the M&A market and featured outside and in‑house lawyers and investment bankers. Ting spoke on a panel entitled “Negotiating the M&A Agreement in the Time of Covid and Beyond,” which reviewed how to mitigate risk in a purchase agreement, the evolution of the Material Adverse Effect clause and interim operating covenants, and Con Ed provisions.
Activities & Publications
January 29, 2024
Cravath partners John W. White and Ting S. Chen participated in Northwestern Pritzker School of Law’s 51st Annual Securities Regulation Institute, which was held from January 22‑24, 2024, in Coronado, CA. The Institute’s keynote David S. Ruder Luncheon Address was a fireside chat between John and Paul Munter, the SEC’s Chief Accountant, exploring audit committee challenges, materiality and the impacts of economic, geopolitical and regulatory uncertainty on accounting today. Ting spoke on a panel entitled “M&A Trends & Developments,” which reviewed the current state of the M&A market, recent M&A litigation and negotiation and contractual issues in the current M&A environment.
Activities & Publications
June 09, 2023
On June 7, 2023, Cravath partner Ting S. Chen participated in the International Bar Association’s 20th Annual International Mergers & Acquisitions Conference, which was held from June 6‑7, 2023 in New York. Ting co‑chaired a panel entitled “Developments in Public Company M&A and Securities Law,” which discussed the ever-evolving landscape of public M&A around the world.
Activities & Publications
March 07, 2023
On March 2, 2023, Cravath partners John W. White, Ting S. Chen, Justin C. Clarke and Michael L. Arnold participated in the 39th Annual Federal Securities Institute, which was hosted by the Business Law Section of the Florida Bar in Miami, Florida from March 2‑3, 2023. John moderated a panel entitled “Accounting in 2023: What Lawyers Should Focus On.” Ting spoke on a panel entitled “Public Company M&A: Turbulent Waters.” Justin spoke on a panel entitled “Private Securities Litigation – Is this a State of Upheaval?” Michael spoke on a panel entitled “Shareholder Activism.”
Activities & Publications
March 03, 2023
On March 1, 2023, Cravath partner Ting S. Chen participated in “Doing Deals 2023: The Art of M&A Transactional Practice,” a program presented by the Practising Law Institute. Ting spoke on a panel entitled “Negotiating the M&A Agreement in the Time of Covid and Beyond,” which reviewed ways to mitigate risk in the merger agreement.
Ting S. Chen focuses her practice on mergers and acquisitions, corporate governance, and activism and takeover defense. Her clients have included Avon, Bacardi, British American Tobacco, DHT, DreamWorks Animation, Global Blood Therapeutics, Honeywell, IBM, Illumina, InterMune, Johnson & Johnson, Kraft, Lundbeck, New Senior, OneBeacon Insurance, Pitney Bowes, Qualcomm, SPANX, Starbucks, Thermo Fisher Scientific, The Washington Post, White Mountains Insurance and Zale Corporation.
Ms. Chen’s notable transactions include representing:
Ms. Chen has been named a “Dealmaker of the Year” by The American Lawyer and has been recognized in IFLR1000’s “Women Leaders – United States,” The Deal’s “Top Women in Dealmaking” and Crain’s New York Business’s “Notable Women in Law.” Ms. Chen has been recognized for her work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000, The Best Lawyers in America and Lawdragon. She has also been recognized by The Legal 500 US for her activist defense work, as well as her transactional work in the media and entertainment and technology industries.
Ms. Chen regularly speaks on topics concerning corporate governance and mergers and acquisitions law. She co‑chaired a panel entitled “Developments in Public Company M&A Securities Law” hosted by the International Bar Association’s Annual International Mergers & Acquisitions Conference and has spoken multiple times at the Practising Law Institute’s (PLI) “Doing Deals: The Art of M&A Transactional Practice” program.
Ms. Chen was born in Taipei, Taiwan. She received an A.B. summa cum laude from Harvard University in 2003, where she was elected to Phi Beta Kappa, and a J.D. from Stanford Law School in 2006.
Ms. Chen joined Cravath in 2006 and was elected a partner in 2013. She currently serves as a member of the Firm’s Diversity Committee.
Ms. Chen’s notable transactions include representing:
Ms. Chen has been named a “Dealmaker of the Year” by The American Lawyer and has been recognized in IFLR1000’s “Women Leaders – United States,” The Deal’s “Top Women in Dealmaking” and Crain’s New York Business’s “Notable Women in Law.” Ms. Chen has been recognized for her work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000, The Best Lawyers in America and Lawdragon. She has also been recognized by The Legal 500 US for her activist defense work, as well as her transactional work in the media and entertainment and technology industries.
Ms. Chen regularly speaks on topics concerning corporate governance and mergers and acquisitions law. She co‑chaired a panel entitled “Developments in Public Company M&A Securities Law” hosted by the International Bar Association’s Annual International Mergers & Acquisitions Conference and has spoken multiple times at the Practising Law Institute’s (PLI) “Doing Deals: The Art of M&A Transactional Practice” program.
Ms. Chen was born in Taipei, Taiwan. She received an A.B. summa cum laude from Harvard University in 2003, where she was elected to Phi Beta Kappa, and a J.D. from Stanford Law School in 2006.
Ms. Chen joined Cravath in 2006 and was elected a partner in 2013. She currently serves as a member of the Firm’s Diversity Committee.
American Bar Association
International Bar Association
New York State Bar Association
The American Lawyer
Best Lawyers in America
Chambers USA
Crain’s New York Business
The Deal
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Law360
Lawdragon
The Legal 500 US
New York Law Journal
Super Lawyers - Rising Stars - New York
Americas Women in Business Law Award ‑ Rising Star: Corporate, Euromoney Legal Media Group (2018, 2016)
Deals & Cases
October 17, 2023
On October 17, 2023, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”), a leading provider of next generation proteomics solutions, announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share in cash. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common shares and all of the American Depositary Shares. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
September 14, 2023
On September 11, 2023, Bacardi Limited (“Bacardi”), the largest privately held international spirits company in the world, announced the completion of a transaction that makes the family‑owned company the sole owner of ILEGAL Mezcal®, a leading super premium artisanal mezcal. Cravath is representing Bacardi in connection with the transaction.
Deals & Cases
May 25, 2023
On May 25, 2023, Illumina, a global leader in DNA sequencing and array‑based technologies, announced that Illumina shareholders have voted to elect eight of nine Illumina director nominees to the Board of Directors. Cravath represented Illumina in connection with these matters.
Deals & Cases
August 08, 2022
On August 8, 2022, Global Blood Therapeutics, Inc. (“GBT”), a biopharmaceutical company dedicated to the discovery, development and delivery of life‑changing treatments that provide hope to underserved patient communities, starting with sickle cell disease, and Pfizer Inc. (“Pfizer”) announced that the companies have entered into a definitive agreement under which Pfizer will acquire GBT. Under the terms of the transaction, Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash, for a total enterprise value of approximately $5.4 billion, including debt and net of cash acquired. Cravath is representing GBT in connection with the transaction.
Deals & Cases
June 21, 2022
On June 21, 2022, Pitney Bowes, a global shipping and mailing company, and Global‑e, a cross‑border end‑to‑end platform for brands and retailers, announced they have entered into a definitive agreement for Global‑e to acquire from Pitney Bowes the Borderfree cross‑border ecommerce solutions business. In addition, the companies will begin a strategic partnership and commercial relationship whereby Pitney Bowes will provide cross‑border ecommerce logistics services to Global‑e and its clients, and Pitney Bowes’s clients will receive access to cross‑border solutions on the Global‑e platform. Cravath is representing Pitney Bowes in connection with the transaction.
Activities & Publications
February 29, 2024
On February 28, 2024, Cravath partner Ting S. Chen participated in “Doing Deals 2024: The Art of M&A Transactional Practice,” a program presented by the Practising Law Institute in New York, which focused on the latest trends and developments in the M&A market and featured outside and in‑house lawyers and investment bankers. Ting spoke on a panel entitled “Negotiating the M&A Agreement in the Time of Covid and Beyond,” which reviewed how to mitigate risk in a purchase agreement, the evolution of the Material Adverse Effect clause and interim operating covenants, and Con Ed provisions.
Activities & Publications
January 29, 2024
Cravath partners John W. White and Ting S. Chen participated in Northwestern Pritzker School of Law’s 51st Annual Securities Regulation Institute, which was held from January 22‑24, 2024, in Coronado, CA. The Institute’s keynote David S. Ruder Luncheon Address was a fireside chat between John and Paul Munter, the SEC’s Chief Accountant, exploring audit committee challenges, materiality and the impacts of economic, geopolitical and regulatory uncertainty on accounting today. Ting spoke on a panel entitled “M&A Trends & Developments,” which reviewed the current state of the M&A market, recent M&A litigation and negotiation and contractual issues in the current M&A environment.
Activities & Publications
June 09, 2023
On June 7, 2023, Cravath partner Ting S. Chen participated in the International Bar Association’s 20th Annual International Mergers & Acquisitions Conference, which was held from June 6‑7, 2023 in New York. Ting co‑chaired a panel entitled “Developments in Public Company M&A and Securities Law,” which discussed the ever-evolving landscape of public M&A around the world.
Activities & Publications
March 07, 2023
On March 2, 2023, Cravath partners John W. White, Ting S. Chen, Justin C. Clarke and Michael L. Arnold participated in the 39th Annual Federal Securities Institute, which was hosted by the Business Law Section of the Florida Bar in Miami, Florida from March 2‑3, 2023. John moderated a panel entitled “Accounting in 2023: What Lawyers Should Focus On.” Ting spoke on a panel entitled “Public Company M&A: Turbulent Waters.” Justin spoke on a panel entitled “Private Securities Litigation – Is this a State of Upheaval?” Michael spoke on a panel entitled “Shareholder Activism.”
Activities & Publications
March 03, 2023
On March 1, 2023, Cravath partner Ting S. Chen participated in “Doing Deals 2023: The Art of M&A Transactional Practice,” a program presented by the Practising Law Institute. Ting spoke on a panel entitled “Negotiating the M&A Agreement in the Time of Covid and Beyond,” which reviewed ways to mitigate risk in the merger agreement.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.